Global Oral Vaccines Sales Market Report 2021

    • ID: AR3033312
    • 01 April, 2021
    • Other
    • Region: Global
    • 147 Pages
    • QYResearch

    1 Oral Vaccines Market Overview

    • 1.1 Oral Vaccines Product Scope
    • 1.2 Oral Vaccines Segment by Type
      • 1.2.1 Global Oral Vaccines Sales by Type (2016 & 2021 & 2027)
      • 1.2.2 Rotavirus Vaccine
      • 1.2.3 Cholera Vaccine
      • 1.2.4 Oral Polio Vaccine
      • 1.2.5 Others
    • 1.3 Oral Vaccines Segment by Application
      • 1.3.1 Global Oral Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
      • 1.3.2 Public
      • 1.3.3 Private
    • 1.4 Oral Vaccines Market Estimates and Forecasts (2016-2027)
      • 1.4.1 Global Oral Vaccines Market Size in Value Growth Rate (2016-2027)
      • 1.4.2 Global Oral Vaccines Market Size in Volume Growth Rate (2016-2027)
      • 1.4.3 Global Oral Vaccines Price Trends (2016-2027)

    2 Oral Vaccines Estimates and Forecasts by Region

    • 2.1 Global Oral Vaccines Market Size by Region: 2016 VS 2021 VS 2027
    • 2.2 Global Oral Vaccines Retrospective Market Scenario by Region (2016-2021)
      • 2.2.1 Global Oral Vaccines Sales Market Share by Region (2016-2021)
      • 2.2.2 Global Oral Vaccines Revenue Market Share by Region (2016-2021)
    • 2.3 Global Oral Vaccines Market Estimates and Forecasts by Region (2022-2027)
      • 2.3.1 Global Oral Vaccines Sales Estimates and Forecasts by Region (2022-2027)
      • 2.3.2 Global Oral Vaccines Revenue Forecast by Region (2022-2027)
    • 2.4 Geographic Market Analysis: Market Facts & Figures
      • 2.4.1 North America Oral Vaccines Estimates and Projections (2016-2027)
      • 2.4.2 Europe Oral Vaccines Estimates and Projections (2016-2027)
      • 2.4.3 China Oral Vaccines Estimates and Projections (2016-2027)
      • 2.4.4 Japan Oral Vaccines Estimates and Projections (2016-2027)
      • 2.4.5 Southeast Asia Oral Vaccines Estimates and Projections (2016-2027)
      • 2.4.6 India Oral Vaccines Estimates and Projections (2016-2027)

    3 Global Oral Vaccines Competition Landscape by Players

    • 3.1 Global Top Oral Vaccines Players by Sales (2016-2021)
    • 3.2 Global Top Oral Vaccines Players by Revenue (2016-2021)
    • 3.3 Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Vaccines as of 2020)
    • 3.4 Global Oral Vaccines Average Price by Company (2016-2021)
    • 3.5 Manufacturers Oral Vaccines Manufacturing Sites, Area Served, Product Type
    • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Global Oral Vaccines Market Size by Type

    • 4.1 Global Oral Vaccines Historic Market Review by Type (2016-2021)
      • 4.1.1 Global Oral Vaccines Sales Market Share by Type (2016-2021)
      • 4.1.2 Global Oral Vaccines Revenue Market Share by Type (2016-2021)
      • 4.1.3 Global Oral Vaccines Price by Type (2016-2021)
    • 4.2 Global Oral Vaccines Market Estimates and Forecasts by Type (2022-2027)
      • 4.2.1 Global Oral Vaccines Sales Forecast by Type (2022-2027)
      • 4.2.2 Global Oral Vaccines Revenue Forecast by Type (2022-2027)
      • 4.2.3 Global Oral Vaccines Price Forecast by Type (2022-2027)

    5 Global Oral Vaccines Market Size by Application

    • 5.1 Global Oral Vaccines Historic Market Review by Application (2016-2021)
      • 5.1.1 Global Oral Vaccines Sales Market Share by Application (2016-2021)
      • 5.1.2 Global Oral Vaccines Revenue Market Share by Application (2016-2021)
      • 5.1.3 Global Oral Vaccines Price by Application (2016-2021)
    • 5.2 Global Oral Vaccines Market Estimates and Forecasts by Application (2022-2027)
      • 5.2.1 Global Oral Vaccines Sales Forecast by Application (2022-2027)
      • 5.2.2 Global Oral Vaccines Revenue Forecast by Application (2022-2027)
      • 5.2.3 Global Oral Vaccines Price Forecast by Application (2022-2027)

    6 North America Oral Vaccines Market Facts & Figures

    • 6.1 North America Oral Vaccines Sales by Company
      • 6.1.1 North America Oral Vaccines Sales by Company (2016-2021)
      • 6.1.2 North America Oral Vaccines Revenue by Company (2016-2021)
    • 6.2 North America Oral Vaccines Sales Breakdown by Type
      • 6.2.1 North America Oral Vaccines Sales Breakdown by Type (2016-2021)
      • 6.2.2 North America Oral Vaccines Sales Breakdown by Type (2022-2027)
    • 6.3 North America Oral Vaccines Sales Breakdown by Application
      • 6.3.1 North America Oral Vaccines Sales Breakdown by Application (2016-2021)
      • 6.3.2 North America Oral Vaccines Sales Breakdown by Application (2022-2027)

    7 Europe Oral Vaccines Market Facts & Figures

    • 7.1 Europe Oral Vaccines Sales by Company
      • 7.1.1 Europe Oral Vaccines Sales by Company (2016-2021)
      • 7.1.2 Europe Oral Vaccines Revenue by Company (2016-2021)
    • 7.2 Europe Oral Vaccines Sales Breakdown by Type
      • 7.2.1 Europe Oral Vaccines Sales Breakdown by Type (2016-2021)
      • 7.2.2 Europe Oral Vaccines Sales Breakdown by Type (2022-2027)
    • 7.3 Europe Oral Vaccines Sales Breakdown by Application
      • 7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
      • 7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)

    8 China Oral Vaccines Market Facts & Figures

    • 8.1 China Oral Vaccines Sales by Company
      • 8.1.1 China Oral Vaccines Sales by Company (2016-2021)
      • 8.1.2 China Oral Vaccines Revenue by Company (2016-2021)
    • 8.2 China Oral Vaccines Sales Breakdown by Type
      • 8.2.1 China Oral Vaccines Sales Breakdown by Type (2016-2021)
      • 8.2.2 China Oral Vaccines Sales Breakdown by Type (2022-2027)
    • 8.3 China Oral Vaccines Sales Breakdown by Application
      • 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
      • 8.3.2 China 314 Sales Breakdown by Application (2022-2027)

    9 Japan Oral Vaccines Market Facts & Figures

    • 9.1 Japan Oral Vaccines Sales by Company
      • 9.1.1 Japan Oral Vaccines Sales by Company (2016-2021)
      • 9.1.2 Japan Oral Vaccines Revenue by Company (2016-2021)
    • 9.2 Japan Oral Vaccines Sales Breakdown by Type
      • 9.2.1 Japan Oral Vaccines Sales Breakdown by Type (2016-2021)
      • 9.2.2 Japan Oral Vaccines Sales Breakdown by Type (2022-2027)
    • 9.3 Japan Oral Vaccines Sales Breakdown by Application
      • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
      • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

    10 Southeast Asia Oral Vaccines Market Facts & Figures

    • 10.1 Southeast Asia Oral Vaccines Sales by Company
      • 10.1.1 Southeast Asia Oral Vaccines Sales by Company (2016-2021)
      • 10.1.2 Southeast Asia Oral Vaccines Revenue by Company (2016-2021)
    • 10.2 Southeast Asia Oral Vaccines Sales Breakdown by Type
      • 10.2.1 Southeast Asia Oral Vaccines Sales Breakdown by Type (2016-2021)
      • 10.2.2 Southeast Asia Oral Vaccines Sales Breakdown by Type (2022-2027)
    • 10.3 Southeast Asia Oral Vaccines Sales Breakdown by Application
      • 10.3.1 Southeast Asia M Doses Sales Breakdown by Application (2016-2021)
      • 10.3.2 Southeast Asia M Doses Sales Breakdown by Application (2022-2027)

    11 India Oral Vaccines Market Facts & Figures

    • 11.1 India Oral Vaccines Sales by Company
      • 11.1.1 India Oral Vaccines Sales by Company (2016-2021)
      • 11.1.2 India Oral Vaccines Revenue by Company (2016-2021)
    • 11.2 India Oral Vaccines Sales Breakdown by Type
      • 11.2.1 India Oral Vaccines Sales Breakdown by Type (2016-2021)
      • 11.2.2 India Oral Vaccines Sales Breakdown by Type (2022-2027)
    • 11.3 India Oral Vaccines Sales Breakdown by Application
      • 11.3.1 India Oral Vaccines Sales Breakdown by Application (2016-2021)
      • 11.3.2 India Oral Vaccines Sales Breakdown by Application (2022-2027)

    12 Company Profiles and Key Figures in Oral Vaccines Business

    • 12.1 Merck
      • 12.1.1 Merck Corporation Information
      • 12.1.2 Merck Business Overview
      • 12.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.1.4 Merck Oral Vaccines Products Offered
      • 12.1.5 Merck Recent Development
    • 12.2 GSK
      • 12.2.1 GSK Corporation Information
      • 12.2.2 GSK Business Overview
      • 12.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.2.4 GSK Oral Vaccines Products Offered
      • 12.2.5 GSK Recent Development
    • 12.3 Sanofi
      • 12.3.1 Sanofi Corporation Information
      • 12.3.2 Sanofi Business Overview
      • 12.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.3.4 Sanofi Oral Vaccines Products Offered
      • 12.3.5 Sanofi Recent Development
    • 12.4 Lanzhou Institute
      • 12.4.1 Lanzhou Institute Corporation Information
      • 12.4.2 Lanzhou Institute Business Overview
      • 12.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.4.4 Lanzhou Institute Oral Vaccines Products Offered
      • 12.4.5 Lanzhou Institute Recent Development
    • 12.5 Serum Institute
      • 12.5.1 Serum Institute Corporation Information
      • 12.5.2 Serum Institute Business Overview
      • 12.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.5.4 Serum Institute Oral Vaccines Products Offered
      • 12.5.5 Serum Institute Recent Development
    • 12.6 Valneva
      • 12.6.1 Valneva Corporation Information
      • 12.6.2 Valneva Business Overview
      • 12.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.6.4 Valneva Oral Vaccines Products Offered
      • 12.6.5 Valneva Recent Development
    • 12.7 Shanghai United Cell
      • 12.7.1 Shanghai United Cell Corporation Information
      • 12.7.2 Shanghai United Cell Business Overview
      • 12.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.7.4 Shanghai United Cell Oral Vaccines Products Offered
      • 12.7.5 Shanghai United Cell Recent Development
    • 12.8 Bibcol
      • 12.8.1 Bibcol Corporation Information
      • 12.8.2 Bibcol Business Overview
      • 12.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.8.4 Bibcol Oral Vaccines Products Offered
      • 12.8.5 Bibcol Recent Development
    • 12.9 PaxVax
      • 12.9.1 PaxVax Corporation Information
      • 12.9.2 PaxVax Business Overview
      • 12.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.9.4 PaxVax Oral Vaccines Products Offered
      • 12.9.5 PaxVax Recent Development
    • 12.10 Vabiotech
      • 12.10.1 Vabiotech Corporation Information
      • 12.10.2 Vabiotech Business Overview
      • 12.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.10.4 Vabiotech Oral Vaccines Products Offered
      • 12.10.5 Vabiotech Recent Development
    • 12.11 Tiantan Biological
      • 12.11.1 Tiantan Biological Corporation Information
      • 12.11.2 Tiantan Biological Business Overview
      • 12.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.11.4 Tiantan Biological Oral Vaccines Products Offered
      • 12.11.5 Tiantan Biological Recent Development
    • 12.12 EuBiologics
      • 12.12.1 EuBiologics Corporation Information
      • 12.12.2 EuBiologics Business Overview
      • 12.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.12.4 EuBiologics Oral Vaccines Products Offered
      • 12.12.5 EuBiologics Recent Development
    • 12.13 Panacea Biotec Ltd
      • 12.13.1 Panacea Biotec Ltd Corporation Information
      • 12.13.2 Panacea Biotec Ltd Business Overview
      • 12.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.13.4 Panacea Biotec Ltd Oral Vaccines Products Offered
      • 12.13.5 Panacea Biotec Ltd Recent Development
    • 12.14 Bio-Med
      • 12.14.1 Bio-Med Corporation Information
      • 12.14.2 Bio-Med Business Overview
      • 12.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.14.4 Bio-Med Oral Vaccines Products Offered
      • 12.14.5 Bio-Med Recent Development
    • 12.15 Halfkin Bio-Pharmaceuticals
      • 12.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
      • 12.15.2 Halfkin Bio-Pharmaceuticals Business Overview
      • 12.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2016-2021)
      • 12.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Products Offered
      • 12.15.5 Halfkin Bio-Pharmaceuticals Recent Development

    13 Oral Vaccines Manufacturing Cost Analysis

    • 13.1 Oral Vaccines Key Raw Materials Analysis
      • 13.1.1 Key Raw Materials
      • 13.1.2 Key Raw Materials Price Trend
      • 13.1.3 Key Suppliers of Raw Materials
    • 13.2 Proportion of Manufacturing Cost Structure
    • 13.3 Manufacturing Process Analysis of Oral Vaccines
    • 13.4 Oral Vaccines Industrial Chain Analysis

    14 Marketing Channel, Distributors and Customers

    • 14.1 Marketing Channel
    • 14.2 Oral Vaccines Distributors List
    • 14.3 Oral Vaccines Customers

    15 Market Dynamics

    • 15.1 Oral Vaccines Market Trends
    • 15.2 Oral Vaccines Drivers
    • 15.3 Oral Vaccines Market Challenges
    • 15.4 Oral Vaccines Market Restraints

    16 Research Findings and Conclusion

      17 Appendix

      • 17.1 Research Methodology
        • 17.1.1 Methodology/Research Approach
        • 17.1.2 Data Source
      • 17.2 Author List

      The global Oral Vaccines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

      Segment by Type
      Rotavirus Vaccine
      Cholera Vaccine
      Oral Polio Vaccine
      Others

      Segment by Application
      Public
      Private

      The Oral Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the Oral Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

      By Company
      Merck
      GSK
      Sanofi
      Lanzhou Institute
      Serum Institute
      Valneva
      Shanghai United Cell
      Bibcol
      PaxVax
      Vabiotech
      Tiantan Biological
      EuBiologics
      Panacea Biotec Ltd
      Bio-Med
      Halfkin Bio-Pharmaceuticals



      Summary:
      Oral Vaccines Market Research Report is about Oral Vaccines Industry study. Get complete Oral Vaccines market research report published after Market Study, Industrial Analysis with Trends & Statistics. Oral Vaccines Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED

      Global Oral Vaccines Sales Market Report 2021

      • 147 Pages
      • Region: Global
      $4,000.00

      Global Poliomyelitis Vaccines Sales Market Report 2021

      • 123 Pages
      • Region: Global
      $4,000.00

      Global Oral Probioics Sales Market Report 2021

      • 140 Pages
      • Region: Global
      $4,000.00

      Global Diphtheria Vaccines Sales Market Report 2021

      • 136 Pages
      • Region: Global
      $4,000.00

      Global Aquaculture Vaccines Sales Market Report 2021

      • 140 Pages
      • Region: Global
      $4,000.00